Gergen Mark J - Insider Non-Derivative Transactions at Poseida Therapeutics, Inc. (PSTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2024, Gergen Mark J's relationship to Poseida Therapeutics, Inc. (PSTX) is Director,Officer (Executive Chairman), and currently has 651,291 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PSTX insiders.
Data Source: SEC.
Gergen Mark J - Insider Non-Derivative Transactions of PSTX Common Stock
Gergen Mark J - Insider Non-Derivative Transactions at PSTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2024 | F -- (Common Stock) | 34157 | 4.13 | 651291 |
| Feb 2, 2024 | F -- (Common Stock) | 47162 | 3.41 | 685448 |
| Jan 3, 2024 | Acquisition -- (Common Stock) | 125000 | 0 | 732610 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 269586 | 0 | 601610 |
| Feb 2, 2023 | F -- (Common Stock) | 31819 | 7 | 330314 |